Matches in SemOpenAlex for { <https://semopenalex.org/work/W2282117445> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2282117445 endingPage "264" @default.
- W2282117445 startingPage "259" @default.
- W2282117445 abstract "Assessing prognosis is important in patients with neuroendocrine tumours of the small bowel as disease progression and survival is variable. We previously identified raised Neurokinin A as an independent indicator of poor prognosis and have shown that prognosis worsens when circulating Neurokinin A rises ≥50 ng/L. In the present study we have examined survival in relation to Neurokinin A concentrations.Patients in whom Neurokinin A rose ≥50 ng/L between January 1989 and December 2010 were identified. All circulating Neurokinin A concentrations were recorded and survival was followed up to 31 December 2014 or to death.Median survival, from the date when Neurokinin A was first ≥50 ng/L was 11.1 (2.0-117.8) months if Neurokinin A remained ≥50 ng/L and 72.4 (4.8-152.6) months when Neurokinin A was reduced below 50 ng/L and controlled below that concentration for ≥3 months (P < 0.001). Survival was significantly better for patients attending the neuroendocrine tumour specialist clinic than for those not attending (P = 0.009). Comparing patients identified during 1989-2000, and those during 2001-2010, Neurokinin A was successfully reduced in the earlier period in 30.3% patients with median survival 23.2 (2.0-152.6) months and this improved in 58.1% with median survival of 43.3 (2.0-141.1) months in the later period (P = 0.019). Significance was greater between the earlier and later periods when only patients attending the neuroendocrine tumour clinic were compared (P = 0.016).Circulating Neurokinin A ≥ 50 ng/L is a strong indicator of poor prognosis when Neurokinin A remains above this concentration. Lowering Neurokinin A below 50 ng/L indicates a significant improvement in prognosis (P < 0.001). This prognostic indicator reflects improved treatment and survival in more recent years." @default.
- W2282117445 created "2016-06-24" @default.
- W2282117445 creator A5000574552 @default.
- W2282117445 creator A5017057649 @default.
- W2282117445 creator A5018487050 @default.
- W2282117445 creator A5018953767 @default.
- W2282117445 date "2015-06-02" @default.
- W2282117445 modified "2023-09-25" @default.
- W2282117445 title "Raised circulating Neurokinin A predicts prognosis in metastatic small bowel neuroendocrine tumours. Lowering Neurokinin A indicates improved prognosis" @default.
- W2282117445 cites W1970282846 @default.
- W2282117445 cites W1973919783 @default.
- W2282117445 cites W1999440266 @default.
- W2282117445 cites W2005735759 @default.
- W2282117445 cites W2020057063 @default.
- W2282117445 cites W2048195661 @default.
- W2282117445 cites W2065462700 @default.
- W2282117445 cites W2069114134 @default.
- W2282117445 cites W2069999129 @default.
- W2282117445 cites W2100296588 @default.
- W2282117445 cites W2102012957 @default.
- W2282117445 cites W2123733004 @default.
- W2282117445 cites W2125398839 @default.
- W2282117445 cites W2128669850 @default.
- W2282117445 cites W2135003342 @default.
- W2282117445 cites W2145891107 @default.
- W2282117445 cites W2146946075 @default.
- W2282117445 cites W2149214723 @default.
- W2282117445 cites W2149684422 @default.
- W2282117445 cites W2170333388 @default.
- W2282117445 cites W2278740836 @default.
- W2282117445 cites W4235213008 @default.
- W2282117445 doi "https://doi.org/10.1177/0004563215592021" @default.
- W2282117445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26038607" @default.
- W2282117445 hasPublicationYear "2015" @default.
- W2282117445 type Work @default.
- W2282117445 sameAs 2282117445 @default.
- W2282117445 citedByCount "5" @default.
- W2282117445 countsByYear W22821174452018 @default.
- W2282117445 countsByYear W22821174452020 @default.
- W2282117445 countsByYear W22821174452023 @default.
- W2282117445 crossrefType "journal-article" @default.
- W2282117445 hasAuthorship W2282117445A5000574552 @default.
- W2282117445 hasAuthorship W2282117445A5017057649 @default.
- W2282117445 hasAuthorship W2282117445A5018487050 @default.
- W2282117445 hasAuthorship W2282117445A5018953767 @default.
- W2282117445 hasBestOaLocation W22821174451 @default.
- W2282117445 hasConcept C118303440 @default.
- W2282117445 hasConcept C126322002 @default.
- W2282117445 hasConcept C137130169 @default.
- W2282117445 hasConcept C170493617 @default.
- W2282117445 hasConcept C2776533618 @default.
- W2282117445 hasConcept C2777056410 @default.
- W2282117445 hasConcept C71924100 @default.
- W2282117445 hasConcept C90924648 @default.
- W2282117445 hasConceptScore W2282117445C118303440 @default.
- W2282117445 hasConceptScore W2282117445C126322002 @default.
- W2282117445 hasConceptScore W2282117445C137130169 @default.
- W2282117445 hasConceptScore W2282117445C170493617 @default.
- W2282117445 hasConceptScore W2282117445C2776533618 @default.
- W2282117445 hasConceptScore W2282117445C2777056410 @default.
- W2282117445 hasConceptScore W2282117445C71924100 @default.
- W2282117445 hasConceptScore W2282117445C90924648 @default.
- W2282117445 hasIssue "2" @default.
- W2282117445 hasLocation W22821174451 @default.
- W2282117445 hasLocation W22821174452 @default.
- W2282117445 hasOpenAccess W2282117445 @default.
- W2282117445 hasPrimaryLocation W22821174451 @default.
- W2282117445 hasRelatedWork W1792780222 @default.
- W2282117445 hasRelatedWork W1972006208 @default.
- W2282117445 hasRelatedWork W2003129473 @default.
- W2282117445 hasRelatedWork W2008379518 @default.
- W2282117445 hasRelatedWork W2042312484 @default.
- W2282117445 hasRelatedWork W2043292850 @default.
- W2282117445 hasRelatedWork W2106349823 @default.
- W2282117445 hasRelatedWork W2965877698 @default.
- W2282117445 hasRelatedWork W3036869701 @default.
- W2282117445 hasRelatedWork W4313368350 @default.
- W2282117445 hasVolume "53" @default.
- W2282117445 isParatext "false" @default.
- W2282117445 isRetracted "false" @default.
- W2282117445 magId "2282117445" @default.
- W2282117445 workType "article" @default.